Facebook
Instagram
Linkedin
Pinterest
Twitter
Youtube
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Tag: Palforzia (AR101)
Study Determines What Patients Prefer for Maintenance After Completing OIT with...
Dave Bloom
-
2023/01/10
Patients chose from continuing with Palforzia or switching to a common food.
This Holiday Season, See the Potential Impact that Peanut Allergy Treatment...
Aimmune
-
2021/12/07
Did you know there’s a treatment option in addition to avoidance alone?
Notebooks, check. Backpack, check. Peanut allergy treatment, check. (Sponsored)
Aimmune
-
2021/10/05
What if you could give your child a treatment option, in addition to practicing a strict peanut-free diet?
USF Begins Recruitment for OIT Study Addressing 15 Food Allergies at...
Dave Bloom
-
2021/09/06
Therapy will treat allergies to peanuts, almonds, cashew, hazelnuts, pecans, pistachios, walnuts, codfish, salmon, shrimp, sesame seed, soy, wheat, milk and eggs simultaneously.
Study: More Than 80% of Patients Could Tolerate 2000mg of Peanuts...
News Wire ~ 3rd Party Press Release
-
2021/08/05
Safety and efficacy increased over time with treatment.
How the First FDA-Approved Therapy for Peanut Allergy is Helping Families (Sponsored)
Aimmune
-
2021/03/17
What is PALFORZIA? PALFORZIA is a treatment for people who are allergic to peanuts. PALFORZIA can help reduce the severity of allergic reactions, including anaphylaxis,...
Aimmune Presents New Clinical Data From Patients Treated With PALFORZIA® for...
News Wire ~ 3rd Party Press Release
-
2021/02/25
Majority of patients experienced low rates of adverse events which declined in frequency and severity with continued treatment.
Peanut Allergy More Common in Adults Than Children, Many Report First...
News Wire ~ 3rd Party Press Release
-
2021/02/09
Peanut allergy affects at least 4.5 million adults in the US.
Nestlé to Acquire Aimmune Therapeutics
News Wire ~ 3rd Party Press Release
-
2020/08/31
Nestlé Health Science and Aimmune to create a global leader in food allergy prevention and treatment.
Results of Aimmune’s Pivotal Phase 3 European Trial of PALFORZIA® Published...
News Wire ~ 3rd Party Press Release
-
2020/07/21
Peanut-allergic patients treated with Palforzia showed desensitization to peanut protein with a predictable safety profile at nine months
1
2
Page 1 of 2